BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12374684)

  • 1. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma.
    Ogi K; Toyota M; Ohe-Toyota M; Tanaka N; Noguchi M; Sonoda T; Kohama G; Tokino T
    Clin Cancer Res; 2002 Oct; 8(10):3164-71. PubMed ID: 12374684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG island methylation in carcinoid and pancreatic endocrine tumors.
    Chan AO; Kim SG; Bedeir A; Issa JP; Hamilton SR; Rashid A
    Oncogene; 2003 Feb; 22(6):924-34. PubMed ID: 12584572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma.
    Ishida E; Nakamura M; Ikuta M; Shimada K; Matsuyoshi S; Kirita T; Konishi N
    Oral Oncol; 2005 Jul; 41(6):614-22. PubMed ID: 15975525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer.
    Bhawal UK; Tsukinoki K; Sasahira T; Sato F; Mori Y; Muto N; Sugiyama M; Kuniyasu H
    Oncol Rep; 2007 Oct; 18(4):817-24. PubMed ID: 17786341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia.
    Garcia-Manero G; Daniel J; Smith TL; Kornblau SM; Lee MS; Kantarjian HM; Issa JP
    Clin Cancer Res; 2002 Jul; 8(7):2217-24. PubMed ID: 12114423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation of multiple genes and clinicopathological relationship of non-small cell lung cancers.
    Hanabata T; Tsukuda K; Toyooka S; Yano M; Aoe M; Nagahiro I; Sano Y; Date H; Shimizu N
    Oncol Rep; 2004 Jul; 12(1):177-80. PubMed ID: 15201980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer.
    Misawa K; Kanazawa T; Misawa Y; Imai A; Endo S; Hakamada K; Mineta H
    Cancer Biomark; 2011-2012; 10(3-4):135-44. PubMed ID: 22674299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas.
    Wu CL; Roz L; McKown S; Sloan P; Read AP; Holland S; Porter S; Scully C; Paterson I; Tavassoli M; Thakker N
    Genes Chromosomes Cancer; 1999 May; 25(1):16-25. PubMed ID: 10221335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma.
    Fukuoka T; Hibi K; Nakao A
    Anticancer Res; 2006; 26(5A):3333-5. PubMed ID: 17094449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.
    Kobatake T; Yano M; Toyooka S; Tsukuda K; Dote H; Kikuchi T; Toyota M; Ouchida M; Aoe M; Date H; Pass HI; Doihara H; Shimizu N
    Oncol Rep; 2004 Nov; 12(5):1087-92. PubMed ID: 15492797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
    Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH
    Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
    Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
    Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of the GATA genes in lung cancer.
    Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
    Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
    Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers.
    Wei SH; Chen CM; Strathdee G; Harnsomburana J; Shyu CR; Rahmatpanah F; Shi H; Ng SW; Yan PS; Nephew KP; Brown R; Huang TH
    Clin Cancer Res; 2002 Jul; 8(7):2246-52. PubMed ID: 12114427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
    Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.